STAT3 and colorectal carcinoma: CCL5 derived from TAMs122 can induce CSN5 expression through the p65/STAT3 pathway and promote stable Programmed Cell Death-Ligand 1 (PD-L1) expression in CRC cells, thus exerting immunosuppressive effects.